Resultados de la búsqueda

The Global MPN Scientific Foundation is pleased to host a special webinar introducing Silence Therapeutics Date:  May 20th, 2025 Time:  6:00 PM – 7:00 PM (CEST) About Silence Therapeutics Silence Therapeutics Silence Therapeutics  collaborates globally to drive forward science  that can make a real impact on I have been in the pharmaceutical industry for 25 years helping mostly small companies like Silence Therapeutics The webinar will cover: An overview of Silence Therapeutics’ scientific approach and platform Their current

On May 20th, 2025, the Global MPN Scientific Foundation  hosted a webinar featuring Silence Therapeutics

Therapeutics , a biotech company developing precision RNA-based therapies for rare diseases such as Alberto Martinez , Senior Director of Clinical Science at Silence Therapeutics. Content guide Part 1: Silence Therapeutics and a Promising New Treatment for PV Watch More on MPN World Part 1: Silence Therapeutics and a Promising New Treatment for PV In the first part, Alberto Martinez Therapeutics is advancing innovative approaches that could help reduce phlebotomies and improve quality

Following the success of our first webinar with Silence Therapeutics , we are excited to announce the This time, we continue on Silence Therapeutics and their investigational therapy for Polycythemia Vera About Silence Therapeutics Webinar Details Register now What to Expect? Alberto Martinez ( Senior Director of Clinical Science at Silence Therapeutics )He will continue explaining About Silence Therapeutics Silence Therapeutics  is a UK-based biotech company developing precision RNA-based

We also hosted and supported webinars on ongoing clinical trials , including sessions with: Silence Therapeutics

Takeda and Protagonist Therapeutics, Inc. , today announced the signing of a worldwide license and collaboration Patel, Ph.D., President and CEO of Protagonist Therapeutics .

The first presentation was given by Alberto Martínez , Senior Director of Clinical Science at Silence Therapeutics , who shared insights on RNA based approaches  in MPNs and how patient-reported outcomes

But you don't have to suffer in silence. But you don't have to suffer in silence.

Verstovsek, world-leading MPN researcher The Global MPN Scientific Foundation, in collaboration with Kartos Therapeutics Content Guide PART 1 – A New Era: Navtemadlin and the Therapeutic Approach Want to watch Parts 2 and Why this matters PART 1 – A New Era: Navtemadlin and the Therapeutic Approach Dr.

Hugh Rienhoff MPN Voice UK Protagonist Therapeutics Let's honor and learn from the awardees: Prof. Summary Transcription Protagonist Therapeutics The award ceremony recognizes Protagonist Therapeutic for its innovative work in developing a new therapeutic product.

this session, we will focus on the first stage post-diagnosis  and engage in automatic writing as a therapeutic Register now  and don’t miss out on this unique opportunity to explore the therapeutic benefits of writing

caregivers , and healthcare professionals  to gain insight into the latest research and innovative therapeutic